Droplet Biosciences
PrivateLast Round
Series A
Dec 13, 2023
Total Funding Raised
$20.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Droplet Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in December 2023.
Droplet Biosciences is a biotechnology company that provides sensitive cancer diagnostics through a non-invasive lymph liquid biopsy platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Droplet Biosciences Comparables
Compare Droplet Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adela | 79% | |
| Quest Diagnostics | 78% | |
| NeoGenomics Inc | 76% |
For institutional investors. Book with your work email.
Droplet Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 13, 2023 | ||||
| Seed | Mar 16, 2023 | ||||
| Seed | May 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Droplet Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 31% MoM, reaching 1.7K.
- Jul 26, 2026
Monthly visitors increased 277% MoM.
For institutional investors. Book with your work email.
Droplet Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Droplet Biosciences's valuation, stock price, and market status.
Is Droplet Biosciences a public or private company?
Droplet Biosciences is a private company.
What is the current stock price of Droplet Biosciences?
Droplet Biosciences is a private company, so its shares have no public market price. Caplight tracks Droplet Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Droplet Biosciences worth (valuation)?
Valuation information for Droplet Biosciences is not publicly available.
Can I buy Droplet Biosciences stock?
Droplet Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Droplet Biosciences's last funding round?
Droplet Biosciences's most recent funding round was Series A on December 13, 2023.
Who are the main investors in Droplet Biosciences?
Key investors in Droplet Biosciences include Engine Ventures.
Will Droplet Biosciences IPO soon?
No public IPO plans have been announced for Droplet Biosciences.
How can I track Droplet Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Droplet Biosciences's shares on secondary markets.